Sigyn Therapeutics (OTCMKTS:SIGY) Issues Earnings Results

Sigyn Therapeutics (OTCMKTS:SIGY) issued its earnings results on Friday. The company reported ($0.36) earnings per share for the quarter, Zacks reports.

Sigyn Therapeutics Trading Up 5.3%

OTCMKTS:SIGY traded up $0.10 during mid-day trading on Friday, hitting $2.00. The stock had a trading volume of 154 shares, compared to its average volume of 303. The company has a 50 day simple moving average of $2.73 and a 200-day simple moving average of $2.95. The stock has a market capitalization of $3.22 million, a price-to-earnings ratio of -0.42 and a beta of -0.88. Sigyn Therapeutics has a 52 week low of $1.90 and a 52 week high of $5.00.

Sigyn Therapeutics Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 21st. Investors of record on Friday, October 24th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 64.0%. The ex-dividend date of this dividend is Friday, October 24th.

About Sigyn Therapeutics

Sigyn Therapeutics, Inc, a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats.